To be held at the Adelaide Convention Centre, the conference will include more than 300 delegates, numerous international speakers and will be the year’s largest gathering of the medtech industry in Australia.
AusBiotech CEO Glenn Cross said the major issues facing the local industry – regulatory, reimbursement and investment would be hot topics at the May 1-2 conference.
“The second key part of the event is getting the key international people here to network with us and talk about the key global issues,” he said.
“When you’re in medtech or biotech, there’s no company or country that just exists by itself so it’s important that we continue to build the global outreach and network.”
The Conference includes a trade exhibition, dinner, networking events and a networking and partnering platform for delegates to schedule 30-minute meetings with other attendees.
Conference delegates will also have the opportunity to tour the world class Adelaide BioMed City next door to the Adelaide Convention Centre and the Tonsley Innovation Precinct, which is emerging as a medical device hub in Adelaide’s southern suburbs.
The CSIRO predicts the global medtech industry to be worth $762 billion by 2025.
Cross said Australia’s medtech industry was growing at 8 to 10 per cent a year. He said the growth was proof that the economy, particularly in the states of South Australia and Victoria, was moving away from traditional manufacturing areas such as automotive and into more advanced areas.
“It’s helping to drive the growth and its providing jobs for a number of people who would not have had jobs,” he said.
“As the local auto manufacturing closed in Melbourne and Adelaide it enabled a number of the supply chain companies to stay open and expand into medical devices.”
The AusMedtech Conference is traditionally held in South Australia or Victoria in recognition of the support those state governments give to the industry.
It will be the first time it has been held at the Adelaide Convention Centre since the centre’s $397 million redevelopment was completed in August 2017.
AusMedtech 2018 program will feature keynote plenary with the inventor of a world-first low cost dialysis system. Vincent Garvey, Chairman and Chief Executive of Ellen Medical Devices and winner of the global Affordable Dialysis Prize in March 2016 will present on his invention.
Also featured will be keynote speaker, Anand Iyer, Co-Founder & Chief Strategy Officer, WellDoc, is a respected global digital health leader—best known for his insights into and experience with technology, strategy and regulatory policy. Anand has been instrumental in WellDoc’s success and the development of BlueStar®, the first FDA-cleared mobile prescription therapy, for adults with type 2 diabetes.
Cross said this week’s conference was “shaping up as a great event” at “one of the great convention centres in Australia”.
“In terms of Aus Biotech, we’re always pleased to bring our major conferences to South Australia, we think the convention centre and the precinct around it is world class,” he said.Jump to next article